A carregar...

Combination Treatment With VELCADE and Low-Dose Tissue Plasminogen Activator Provides Potent Neuroprotection in Aged Rats After Embolic Focal Ischemia

BACKGROUND AND PURPOSE: Treatment with a selective proteasome inhibitor, VELCADE, in combination with tissue plasminogen activator (tPA) extended the therapeutic window to 6 hours in young rats after stroke. However, stroke is a major cause of death and disability in the elderly. The present study i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhang, Li, Zhang, Zheng Gang, Buller, Ben, Jiang, James, Jiang, Yanting, Zhao, Danping, Liu, Xianshuang, Morris, Dan, Chopp, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860668/
https://ncbi.nlm.nih.gov/pubmed/20203318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.109.577288
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!